Literature DB >> 6410860

Intracarotid chemotherapy of glioblastoma after induced blood-brain barrier disruption.

C T Bonstelle, S H Kori, H Rekate.   

Abstract

Intracarotid chemotherapy has been suggested as an additional mode of therapy in patients with brain tumors. Seven comatose patients received intracarotid 5-fluorouracil and adriamycin after intracarotid infusion of 25% mannitol to open the blood-brain barrier at the tumor site. Five of seven patients became fully functional for 3-12 months. Another 11 patients entered the study, of which nine are currently receiving therapy and are functional, and two have died, one from brain herniation. The results are encouraging and support the need for further research of this therapeutic method.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6410860      PMCID: PMC8334987     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  4 in total

Review 1.  Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.

Authors:  M S Mahaley
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130

2.  Uptake of adriamycin in tumour and surrounding brain tissue in patients with malignant gliomas.

Authors:  H von Holst; E Knochenhauer; H Blomgren; V P Collins; L Ehn; M Lindquist; G Norén; C Peterson
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

3.  Superselective intra-arterial carboplatin for treatment of intracranial neoplasms: experience in 100 procedures.

Authors:  A I Qureshi; M F Suri; J Khan; M Sharma; K Olson; L R Guterman; L N Hopkins
Journal:  J Neurooncol       Date:  2001-01       Impact factor: 4.130

4.  Osmotic blood-brain barrier disruption and chemotherapy in the treatment of high grade malignant glioma: patient series and literature review.

Authors:  M K Gumerlock; B D Belshe; R Madsen; C Watts
Journal:  J Neurooncol       Date:  1992-01       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.